Jupiter Neurosciences, Inc. Common Stock (JUNS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $2.32M
Last updated: Nov 17, 2026 at 11:05 AM ET
Earnings
Performance (10Y)
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 36.4% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 30.6, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about JUNS
News
JUNS Valuation
GNG's valuation label for JUNS is Undervalued. It trades at 28.6x forward earnings.
- Forward P/E
- 28.6x
- P/B
- -1.4x
JUNS Profitability: Margins, ROIC and FCF
Jupiter Neurosciences, Inc. Common Stock (JUNS) has a gross margin of 79.5%, an operating margin of -15167.0% and a net margin of 0.0%. It posts 1154.5% ROIC and a -11210.5% FCF margin.
- Gross margin
- 79.5%
- Operating margin
- -15167.0%
- Net margin
- 0.0%
- ROIC
- 1154.5%
- ROE
- -1889.0%
- FCF margin
- -11210.5%
Jupiter Neurosciences, Inc. Common Stock Competitors
The companies most similar to Jupiter Neurosciences, Inc. Common Stock (JUNS) include Revelation Biosciences, Neurosense Therapeutics and BioRestorative Therapies.
Sector: Healthcare
Companies most similar to Jupiter Neurosciences, Inc. Common StockJUNS Bull Case vs Bear Case
Bull case
- JUNS earns a 1154.5% return on invested capital.
Bear case
- JUNS beat EPS estimates in 14.3% of its last 7 reported quarters.
JUNS Earnings: Beat Rate
Jupiter Neurosciences, Inc. Common Stock (JUNS) beat the EPS estimate in 1 of the 7 most recent quarters that had an estimate (14.3%).
- Beat rate
- 1 of 7 quarters (14.3%)
- Average surprise
- -35.1%
JUNS ETF Holders
GNG tracks 1 ETF that holds JUNS.
- Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX), <0.01% of the fund
Updated Nov 16, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About JUNS
Does JUNS pay dividends?
Jupiter Neurosciences, Inc. Common Stock (JUNS) does not currently pay a regular dividend.
What is JUNS's market cap?
Jupiter Neurosciences, Inc. Common Stock (JUNS) has a market capitalization of $2.32M with a current stock price of $1.70.
Is JUNS stock overvalued?
GNG's valuation label for JUNS is Undervalued. Jupiter Neurosciences, Inc. Common Stock (JUNS) trades at 28.6x forward earnings.
JUNS pages: Overview, Financials, Competitors
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.